PSMA PETCT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI findings are negative or inconclusive yet have persistent clinical risk factors. According to new research published in the September issue of The Journal of Nuclear Medicine, combining the two biopsy approaches is even more effective, nearly doubling the […]
Read MoreRandomised trial links treatment to sustained symptom relief, less joint deterioration and lower disability risk, with fewer knee replacements in patients with grade II disease ASTRO Expert Perspective: “For osteoarthritis, we have treatments that can help patients feel better, but much less evidence that they can change what is happening inside the joint. What makes these […]
Read MoreThe innovation may help improve the fMRI experience for patients, while expanding opportunities for brain research. Functional magnetic resonance imaging, or fMRI, gives researchers a powerful way to study brain activity. But the scans can be incredibly noisy for patients and research subjects, with peak sound levels reaching 120 to 138 decibels — about as […]
Read MoreNew research from UCL and UCLH suggests that prostate cancer in some men can be identified from an MRI scan with a very high degree of confidence, potentially reducing the need for a biopsy. Four experienced radiologists, working both individually and as a group, identified a subset of patients in whom they were ‘99 per […]
Read More